Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Prognosis
406 results:

  • 1. Inhibition of pi3k/AKT signaling using BKM120 reduced the proliferation and migration potentials of colorectal cancer cells and enhanced cisplatin-induced cytotoxicity.
    Khameneh SC; Sari S; Razi S; Yousefi AM; Bashash D
    Mol Biol Rep; 2024 Mar; 51(1):420. PubMed ID: 38483663
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma.
    Wang WP; Shi D; Yun D; Hu J; Wang JF; Liu J; Yang YP; Li MR; Wang JF; Kong DL
    World J Gastroenterol; 2024 Feb; 30(6):565-578. PubMed ID: 38463028
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the pi3k/Akt/mTOR signaling pathway].
    Tao SN; Liu XC; Wang YY; Yang H
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
    [No Abstract]    [Full Text] [Related]  

  • 4. Negative prognostic impact of Co-mutations in TGFβ and TP53 pathways in surgically resected rectal tumors following neoadjuvant chemoradiotherapy.
    Qian C; Yang W; Li M; Feng Y; Dai N; Luo H; Jian D; Li X; Yang Y; He Y; Wang D; Li C; Xiao H
    Eur J Surg Oncol; 2024 Apr; 50(4):108242. PubMed ID: 38460248
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer.
    Liu H; Zhou D; Liu D; Xu X; Zhang K; Hu R; Xiong P; Wang C; Zeng X; Wang L; Zhang S
    Cell Death Dis; 2024 Mar; 15(3):187. PubMed ID: 38443386
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer.
    Lv Q; Zhang Y; Gao W; Wang J; Hu Y; Yang H; Xie Y; Lv Y; Zhang H; Wu D; Hu L; Wang J
    Pharmacol Res; 2024 Apr; 202():107126. PubMed ID: 38432446
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate pi3k-Akt-mTOR pathway and is a therapeutic target.
    Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
    Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic specificity study using next-generation sequencing (NGS) of peritoneal metastatic colorectal cancer compared to primary colorectal cancer.
    Lee S; Shin W; Park DG; Namgung H
    Genes Genomics; 2024 Mar; 46(3):289-302. PubMed ID: 38316717
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrating cfDNA liquid biopsy and organoid-based drug screening reveals pi3k signaling as a promising therapeutic target in colorectal cancer.
    Yang H; Xiao X; Zeng L; Zeng H; Zheng Y; Wang J; Li G; Dai W; He Y; Wang S; Peng J; Chen W
    J Transl Med; 2024 Feb; 22(1):132. PubMed ID: 38310289
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Role of PAX6, TRPA1, BCL11B, MCOLN2, CUX1, EMX1 in colorectal cancer and osteosarcoma.
    Zhang J; Gao Q; Hou S; Chi X; Zheng M; Zhang Q; Shan H; Zhang X; Kang C
    Medicine (Baltimore); 2024 Feb; 103(5):e37056. PubMed ID: 38306561
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway.
    Zhang Z; Jiang X; Li K; Qiao S; Li M; Mei Y; Ding L; Lv Q; Ding Y; Zhao Y; Lv G; Tan G; Yang H; Li G; Gao X; Liu M
    Int J Biol Sci; 2024; 20(1):387-402. PubMed ID: 38164176
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
    BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ADORA2A promotes proliferation and inhibits apoptosis through pi3k/AKT pathway activation in colorectal carcinoma.
    Ran L; Mou X; Peng Z; Li X; Li M; Xu D; Yang Z; Sun X; Yin T
    Sci Rep; 2023 Nov; 13(1):19477. PubMed ID: 37945707
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.
    Ottaiano A; De Luca A; Santorsola M; Scognamiglio G; Di Mauro A; Chiodini P; Lambiase M; Sacco A; Petrillo A; Granata V; Fusco R; Mercadante E; Martucci N; De Luca G; Rocca A; Celentano E; Crispo A; Di Gennaro P; Tatangelo F; Ferrara G; Izzo F; Belli A; Patrone R; Delrio P; Rega D; De Franciscis S; Muto P; Ravo V; Di Franco R; Borzillo V; Santagata S; Rea G; Castaldo D; Pace U; De Feo G; Scala S; Nasti G; Normanno N
    BMC Cancer; 2023 Oct; 23(1):1010. PubMed ID: 37858132
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. RFC2 promotes aerobic glycolysis and progression of colorectal cancer.
    Lou F; Zhang M
    BMC Gastroenterol; 2023 Oct; 23(1):353. PubMed ID: 37821801
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. NIFK as a potential prognostic biomarker in colorectal cancer correlating with immune infiltrates.
    Tan L; He Y; Wu L; Liu S; Peng P; Huang J
    Medicine (Baltimore); 2023 Oct; 102(40):e35452. PubMed ID: 37800782
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. colorectal cancer: Genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials.
    Housini M; Dariya B; Ahmed N; Stevens A; Fiadjoe H; Nagaraju GP; Basha R
    Gene; 2024 Jan; 892():147857. PubMed ID: 37783294
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the pi3k/AKT pathway.
    Wu M; Li R; Qin J; Wang Z; Guo J; Lv F; Wang G; Huang Y
    J Mol Histol; 2023 Dec; 54(6):621-631. PubMed ID: 37776473
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. CHSY1 promotes CD8
    Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
    J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mutation Profile via Next-Generation Sequencing in Patients with colorectal Adenocarcinoma and Its Clinicopathological Correlation.
    Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
    Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
    [TBL] [Abstract] [Full Text] [Related]  


    of 21.